Konstantinos Drosopoulos
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Integration of RNAi and Small Molecule Library Screens to Identify Targets for Drug Discovery.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 31, 2025
Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes.
Journal: Journal of medicinal chemistry
Published: February 07, 2023
Integration of RNAi and Small Molecule Screens to Identify Targets for Drug Development.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 27, 2019
High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers.
Journal: Molecular cancer therapeutics
Published: October 22, 2018
RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses.
Journal: British journal of cancer
Published: May 08, 2017
Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer.
Journal: Nature communications
Published: March 03, 2017
APC/C is an essential regulator of centrosome clustering.
Journal: Nature communications
Published: December 06, 2013
Integration of RNAi and small molecule screens to identify targets for drug development.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 26, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026